Per M. Almqvist
Corporate Officer/Principal bei Karolinska Institutet
Profil
Per M.
Almqvist is currently a Principal at Karolinska Institutet.
Previously, he worked as a Director-Clinical Development at Bok Holding A.
Aktive Positionen von Per M. Almqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | 13.08.2009 |
Ehemalige bekannte Positionen von Per M. Almqvist
| Unternehmen | Position | Ende |
|---|---|---|
Bok Holding A/S
 Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Bok Holding A/S
Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Health Technology |
